We are live on ! Find out more
Data Collective IV

Data Collective IV Portfolio holdings

AUM $63.3M Turnover 0%
1-Year Est. Return 21.22%
This Fund
S&P 500
This Quarter Est. Return
-24.04%
1 Year Est. Return
+21.22%
3 Year Est. Return
+306.43%
5 Year Est. Return
+112.38%
10 Year Est. Return
–
AUM
$121M
AUM Growth
-$350M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
–
Closed
–
Avg Time Held
0.5 years
Top 10 Avg Time Held
0.5 years
Top 20 Avg Time Held
0.5 years

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 40.96%
2 Industrials 32.45%
3 Technology 26.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
RXRX icon
1
Recursion Pharmaceuticals
RXRX
$1.81B
$48.4M 39.94%
5,941,120
– –
2021 Q4
2 quarters
EMBK
2
DELISTED
Embark Technology
EMBK
$32.2M 26.59%
3,186,008
– –
2021 Q4
2 quarters
EVLV icon
3
Evolv Technologies
EVLV
$714M
$28.2M 23.29%
10,601,281
– –
2021 Q4
2 quarters
RKLB icon
4
Rocket Lab
RKLB
$38.6B
$11.1M 9.17%
2,929,350
– –
2021 Q4
2 quarters
DFTX icon
5
Definium Therapeutics
DFTX
$4.39B
$1.23M 1.02%
100,350
– –
2021 Q4
2 quarters

Similar funds

Data Collective IV's Q2 2022 Portfolio in Review

As of Q2 2022, Data Collective IV held 5 positions worth $121M, down 74% from $471M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2022: portfolio turnover was 0%. Data Collective IV opened no new positions and made no exits, leaving the 5-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, up from 9.4% a quarter earlier, followed by Industrials and Technology.

  • Data Collective IV's ten largest holdings make up 100% of its $121M portfolio in Q2 2022.
  • Data Collective IV opened 0 new positions and closed 0 in Q2 2022.
  • Data Collective IV's portfolio value fell 74% quarter-over-quarter to $121M.

Based on Data Collective IV's 13F filing for Q2 2022, filed 14 Nov 2022.